Roundhill Glp-1 & Weight ... (OZEM)
NasdaqGM: OZEM
· Echtzeitkurs · USD
33.61
+0.09 (0.27%)
Zum Schluss: Aug 13, 2026, 11:36 AM
Roundhill Glp-1 & Weight Loss ETF (OZEM) ETF Price, Holdings & Analysis
0.27% (1D)
| Geld | 23.33 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 61.38 Mio |
| NAV | 33.58 |
| Beta | k.A. |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 14.83 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | May 20, 2024 |
| Brief | 41.71 |
| Volumen | 4,153 |
| Ø Vol. (20D) | 23,609 |
| Eröffnung | 33.52 |
| Vortagesschluss | 33.52 |
| Tagesspanne | 33.39 - 33.61 |
| 52-Wk Range | 24.30 - 37.15 |
| Positionen | k.A. |
| Kostenquote | 0.59% |
Über OZEM
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.
Anlageklasse Equity
Tickersymbol OZEM
Auflagedatum May 20, 2024
Anbieter Roundhill Investments
Website Fonds-Homepage
Börse NasdaqGM
Top 10 Positionen 64.59% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Novo Nordisk As Adr | NVO | 12.96% |
| Eli Lilly And Co | LLY | 12.36% |
| Pfizer Inc | PFE | 6.75% |
| Cspc Pharmaceutical ... | 1093.HK | 6.65% |
| Kailera Therapeutics... | KLRA | 4.86% |
| Viking Therapeutics ... | VKTX | 4.85% |
| Chugai Pharmaceutica... | 4519.T | 4.29% |
| Zealand Pharma As | ZEAL.CO | 4.22% |
| Amgen Inc | AMGN | 4.16% |
| Astrazeneca PLC | AZN.L | 3.49% |
Dividenden Dividendenrendite 1.22%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 30, 2025 | $0.4100 | k.A. |
| Dec 30, 2024 | $0.0530 | k.A. |
Seite 1 von 2